Tenderwize
Back to tender search

Open House Drug Discount Agreement Vilanterol/Umeclidiniumbromide

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Apr 03, 2028 · 595 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Vilanterol und Umeclidiniumbromid, ATC R03AL03

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

No estimated value or volume provided. The open-house model offers no commitment to purchase, so revenue is unpredictab...

The agreement automatically lapses if a standard discount contract (via formal procurement) is concluded for the same a...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until May 2028
  • Pharmaceutical products: Vilanterol and Umeclidiniumbromid (ATC R03AL03)
  • Non-exclusive discount agreements under §130c SGB V
Show full summary

Open-house model for non-exclusive drug discount agreements for Vilanterol/Umeclidiniumbromid (ATC R03AL03) by AOK Bayern. Any eligible pharmaceutical company can join; no competition, but no guaranteed volume or value. Contracts run from earliest 01.06.2026 to 31.05.2028. Deadline for applications is 03.04.2028, but contracts can be concluded monthly if applications are complete by the 3rd of each month.

Risks

No estimated value or volume provided. The open-house model offers no commitment to purchase, so revenue is unpredictab...

The agreement automatically lapses if a standard discount contract (via formal procurement) is concluded for the same a...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical company (pharmazeutischer Unternehmer)

Administrative

  • Submit signed contract, annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and self-declaration of reliability
  • Documents may be submitted in paper form (signed by hand, 2 copies) or electronically with qualified electronic signature via dtvp.de

Requirements may be incomplete.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open House Drug Discount Agreement Vilanterol/Umeclidiniumbromide

Non-exclusive discount agreement for pharmaceutical products with active substances Vilanterol and Umeclidiniumbromid (ATC R03AL03). All interested pharmaceutical companies meeting eligibility can join. No selection; all accepted. Contract duration 24 months, with possible early termination if other agreements supersede.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

May 2026 - May 2028

Category

Pharmaceutical products

Deadline

Deadline Apr 03, 2028

Procurement Details

Publication date
14 Apr 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
254799-2026

Documents (2)

Similar tenders